- Home
- ABT
as 11-18-2024 4:00pm EST
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Founded: | 1888 | Country: | United States |
| Employees: | N/A | City: | ABBOTT PARK |
| Market Cap: | 177.5B | IPO Year: | N/A |
| Target Price: | $129.25 | AVG Volume (30 days): | 5.1M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.29 | EPS Growth: | 12.04 |
| 52 Week Low/High: | $98.95 - $121.64 | Next Earning Date: | 10-16-2024 |
| Revenue: | $41,217,000,000 | Revenue Growth: | 3.15% |
| Revenue Growth (this year): | 5.76% | Revenue Growth (next year): | 7.18% |
Stock Insider Trading Activity of Abbott Laboratories (ABT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ford Robert B | ABT | CHAIRMAN AND CEO | Sep 12 '24 | Sell | $116.47 | 141,679 | $16,493,217.96 | 281,439 | |
| MCCOY JOHN A. JR. | ABT | VICE PRESIDENT | Sep 1 '24 | Sell | $114.83 | 27 | $3,100.41 | 18,681 |
Latest Abbott Laboratories News
ABT Breaking Stock News: Dive into ABT Ticker-Specific Updates for Smart Investing
Yahoo Finance
19 hours ago
Inside a $400 billion bet on the brain-computer interface revolution
Argus Research
a day ago
Weekly Stock List
Insider Monkey
2 days ago
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now
Motley Fool
5 days ago
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
Medical Device Network
6 days ago
US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024
GuruFocus.com
6 days ago
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories
Simply Wall St.
6 days ago
Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years
Simply Wall St.
10 days ago
Is Abbott Laboratories' (NYSE:ABT) Recent Stock Performance Influenced By Its Financials In Any Way?
Compare ABT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABT Abbott Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.